Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000253476 | SCV000319919 | uncertain significance | Cardiovascular phenotype | 2024-11-15 | criteria provided, single submitter | clinical testing | The p.R2571L variant (also known as c.7712G>T), located in coding exon 53 of the DMD gene, results from a G to T substitution at nucleotide position 7712. The arginine at codon 2571 is replaced by leucine, an amino acid with dissimilar properties. Based on data from gnomAD, the T allele has an overall frequency of 0.0029% (6/204894) total alleles studied, with 2 hemizygote(s) observed. The highest observed frequency was 0.0214% (6/28040) of Latino alleles. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the available evidence, the clinical significance of this variant remains unclear. |
Labcorp Genetics |
RCV001246274 | SCV001419616 | likely benign | Duchenne muscular dystrophy | 2023-07-15 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002494792 | SCV002776045 | uncertain significance | Becker muscular dystrophy; Duchenne muscular dystrophy; Dilated cardiomyopathy 3B | 2021-12-05 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001828165 | SCV002087736 | uncertain significance | Becker muscular dystrophy; Duchenne muscular dystrophy; Cardiomyopathy; Dystrophin deficiency | 2019-03-27 | no assertion criteria provided | clinical testing |